Loading
Cerebrovascular and Carotid Artery Diseases · Journal article
Contemporary Clinical Trials · September 1, 2026
A consensus or society position rather than new primary data.
This is a methodological critique and design guidance paper that identifies recurrent problems in randomised trials comparing surgery to conservative management in neurosurgery—particularly the temporal asymmetry between acute surgical risk and distributed long-term conservative hazard—and proposes a portfolio of design strategies borrowed from other specialties. The paper does not report empirical trial results but rather a conceptual framework intended to guide future trial design and improve the trustworthiness and applicability of evidence in this field.
Journal article. Patients in neurosurgery requiring decision between surgical and conservative management for conditions with rare incidence and decades-long natural histories; illustrative examples drawn from ARUBA (unruptured brain arteriovenous malformations) and COSS/CMOSS trials (symptomatic carotid occlusion).
Recurrent problems in surgery-versus-conservative trials include contestable equipoise, ambiguous eligibility, heterogeneous interventional arms, mismatched follow-up to natural history, restricted external validity, and uncritical extrapolation beyond randomised population Most consequential problems are conceptual rather than statistical: investigators fail to design trials matching the temporal structure of the actual clinical decision Proposed strategies include expertise-based randomisation, cohort-embedded designs, adaptive designs with informative natural-history priors, platform protocols with shared control arm, risk-stratified enrichment, and pre-specified lifetime microsimulation
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians and trialists designing surgery-versus-conservative studies should recognise that conventional trial methodology may fail to capture the true clinical decision and should consider adopting the proposed design strategies—expertise-based randomisation, cohort-embedded designs, adaptive designs with natural-history priors, and pre-specified lifetime modelling—to produce evidence that better informs practice.
A methodological critique and design framework for surgery-versus-conservative trials in neurosurgery, proposing solutions to recurrent conceptual and statistical problems in trial design rather than reporting new empirical results.
Clinicians and trialists designing surgery-versus-conservative studies should recognise that conventional trial methodology may fail to capture the true clinical decision and should consider adopting the proposed design strategies—expertise-based randomisation, cohort-embedded designs, adaptive designs with natural-history priors, and pre-specified lifetime modelling—to produce evidence that better informs practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
BACKGROUND: Randomised trials that compare a surgical intervention to medical or conservative management occupy a peculiar space in clinical research. The two arms are not symmetric in time: surgery imposes a concentrated, acute risk in exchange for a long-term benefit, whereas conservative management distributes a smaller hazard across the patient's remaining life. In neurosurgery, where the conditions under study are frequently rare and natural histories are measured in decades, this asymmetry exposes weaknesses in conventional trial methodology that have repeatedly led to inconclusive, non-generalisable, or actively misleading results. DISCUSSION: Using as illustrations the ARUBA trial of interventional therapy for unruptured brain arteriovenous malformations and the COSS and CMOSS trials of extracranial-intracranial bypass for symptomatic carotid occlusion, we identify the recurrent problems of surgery-versus-conservative trials: contestable equipoise, ambiguous eligibility, heterogeneous interventional arms, mismatched follow-up to the natural history of disease, restricted external validity, and uncritical extrapolation beyond the population actually randomised. We argue that the most consequential of these problems are not statistical but conceptual: investigators repeatedly fail to design trials in which the temporal structure matches the clinical decision the patient is actually making. CONCLUSION: We propose a portfolio of design strategies, several borrowed from oncology, critical care, and cardiology, including expertise-based randomisation, cohort-embedded designs, adaptive designs with informative natural-history priors, platform protocols with a shared control arm, risk-stratified enrichment, and pre-specified lifetime microsimulation. Properly combined, these designs may yield evidence that physicians trust and apply, rather than evidence physicians cite while continuing to operate as before.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.